Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Tom Nolte & Boon Yap
  • May 30, 2019
  • Videos

What to consider when conducting pricing research

Tom Nolte, Director of Business Analytics and Boon Yap, Associate Consultant discuss how to use qualitative research and integrated modelling to optimise price and inform demand forecasts.

read more »

  • Posted by Brett Gardiner & Boon Yap
  • May 20, 2019
  • Articles

China in the fast lane: Access opportunities for novel therapies in the world's hottest emerging market

China in the fast lane: Access opportunities for novel therapies in the world's hottest emerging market

In our latest article for pharmaphorum's Deep Dive magazine, Brett Gardiner and Boon Yap discuss access opportunities for novel therapies in the world’s hottest emerging market.

The sheer size of China’s population (1.4 billion) has long made it an attractive market for pharma in terms of potential volume, especially in the context of rising affluence associated with a growing middle class. In 2017, China was ranked the second largest pharmaceutical market in the world, behind the US. However, it has traditionally been a challenging market to launch into, particularly for manufacturers developing innovative and novel therapies. Recent changes to China’s regulations under its 2025 Made in China strategic plan – including an expedited market access process, more frequent updates to Reimbursed Drugs Listings and additional routes to reimbursement – look set to transform this paradigm and necessitate a reconsideration of manufacturers’ strategies to obtaining optimal pricing and reimbursement (P&R).

read more »

  • Posted by Rachel Howard, Brett Gardiner
  • April 8, 2019
  • Events

World Pharma Pricing and Market Access Congress 2019

World Pharma Pricing and Market Access Congress 2019

Last month, Directors Brett Gardiner and Rachel Howard attended the World Pharma Pricing and Market Access Congress in Amsterdam.

This two-day event was attended by over 600 delegates, including a number of payers from Europe, the US and Latin America, plus representatives from the industry and other market access organizations. In the morning plenary sessions, we heard a range of perspectives on value, demonstrating that “value is in the eye of the beholder”. A major focus was the new challenges facing Health Technology Assessment (HTA) organizations in view of the expanding pipeline of Advanced Therapy Medicinal Products (ATMPs) such as cell and gene therapy.

read more »

How we assessed the access potential of a new product in order to develop a successful launch strategy

How we assessed the access potential of a new product in order to develop a successful launch strategy

Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.

To ensure a fast and successful launch they wanted to develop key strategies to maximise acceptance and reimbursement of their product amongst HCPs and Payers. 

read more »

How we facilitated mock negotiations with payers to improve the pricing strategy for a new biologic in Latin America

How we facilitated mock negotiations with payers to improve the pricing strategy for a new biologic in Latin America

Our client wanted to understand how they should manage payer objections within the value proposition, clinical evidence and economic value of the product.

At offered prices, it would be cost-effective and have comparable / lower net budget impact than analogues. However, payers in Latin America were still expected to add further barriers or reject the reimbursement request. As a result our client wanted to understand how they should manage payer objections within the value proposition, clinical evidence and economic value of the product.

read more »